erythropoetin beta
Recombinant proteinexperimental
Clinical trial activity
8 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
2
Phase 4
1
Earliest trial started Jan 1, 2004 (NCT00284271)
Timeline
Indications
Approved for
Mechanism of action
- Erythropoietin receptorAGONIST
EPOR agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- erythropoetin beta
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03786289 | Phase 1 | Dec 3, 2018 | Fortune Rock |
| NCT01732146 | Phase 3 | Mar 1, 2013 | University of Paris |
| NCT00551291 | Phase 2 | Aug 1, 2007 | Roche |
| NCT00654992 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2006 | Seoul National University |
| NCT00568542 | Phase 4 | May 1, 2006 | Humboldt University |
| NCT03867071 | N/A | Oct 31, 2005 | Centre Hospitalier Universitaire de Nīmes |
| NCT00140010 | Phase 2 | Apr 1, 2005 | Roche, University of Cambridge |
| NCT00284271 | Phase 2 | Jan 1, 2004 | University of Cologne |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 2 | 1 | 1 | 2005 |
| Centre Hospitalier Universitaire de Nīmes | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Fortune Rock | For profit | 1 | 1 | 1 | 2018 |
| Humboldt University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Seoul National University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| University of Cambridge | Academic/Hospital | 1 | 1 | 1 | 2005 |
| University of Cologne | Academic/Hospital | 1 | 1 | 1 | 2004 |
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2013 |
8 organizations
Page 1 / 1